NCT05920408View on ClinicalTrials.gov

Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

September 27, 2023

Study Completion Date

October 23, 2023

Conditions
Advanced Solid Tumours
Interventions
DRUG

EXS21546

EXS21546 Granule in Capsule

Trial Locations (5)

21000

Centre GF Leclerc, Dijon

Unknown

Institute Jules Bordet, Brussels

CHU Mont-Godinne, Namur

Institut Bergonie, Bordeaux

Centre Eugene Marquis, Rennes

Sponsors

Collaborators (1)

Biotrial
All Listed Sponsors
collaborator

Biotrial

INDUSTRY

lead

Exscientia AI Limited

INDUSTRY

NCT05920408 - Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours | Biotech Hunter | Biotech Hunter